SCHEMBL8946587

SCHEMBL8946587

CC(=O)Nc1ccc2c(c1)C1Cc3ccccc3C1N2C(C)=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
ALDH1A1 P00352 2/20 0.49
HTR2C P28335 2/20 0.45
HTR2B P41595 2/20 0.45
CYP1A2 P05177 1/20 0.45
ADRA2A P08913 1/20 0.45
MAOA P21397 1/20 0.45
SLC6A2 P23975 1/20 0.45
SLC6A4 P31645 1/20 0.45
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
SLC9A3 P48764 2/20 0.42
CYP2D6 P10635 1/20 0.42
CREBBP Q92793 1/20 0.41
MAPT P10636 3/20 0.41
HTR2A P28223 2/20 0.40
HTR1A P08908 1/20 0.40
BRD4 O60885 1/20 0.39
BRD2 P25440 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8946434 0.82 HSD17B3 (0.44) L3MBTL1ALDH1A1CREBBPMAPTBRD4
SCHEMBL8946435 0.78 MAPT (0.47) KDM4EALDH1A1HTR2CHTR2BNPC1
SCHEMBL8946786 0.77 CREBBP (0.40) L3MBTL1ALDH1A1CYP1A2CREBBPMAPT
SCHEMBL10438249 0.68 GRIN2D (0.55) KDM4EL3MBTL1ALDH1A1HTR2CHTR2B
SCHEMBL15383120 0.67 NOTUM (0.40) KDM4EALDH1A1CREBBPBRD4SMN1; SMN2
SCHEMBL21371548 0.67 NOTUM (0.40) KDM4EALDH1A1CREBBPBRD4SMN1; SMN2
SCHEMBL6949098 0.66 MAOA (0.56) KDM4EL3MBTL1ALDH1A1MAOANPC1
SCHEMBL8946692 0.65 HSD17B3 (0.39) KDM4EALDH1A1CREBBPMAPTBRD4
SCHEMBL8946697 0.65 HSD17B3 (0.39) KDM4EALDH1A1CREBBPMAPTBRD4
SCHEMBL8946705 0.65 HSD17B3 (0.39) KDM4EALDH1A1CREBBPMAPTBRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5516788-A TREATMENT OF ATHEROSCLEROSIS; ANTIISCHEMIC, ANTICARCINOGENIC AGENTS; ANTICOAGULANTS UNIVERSITY OF BATH (GB) 1996-05-14 US disclosed